{"DataElement":{"publicId":"6161017","version":"1","preferredName":"ICD-O Disease Diagnosis Category","preferredDefinition":"The text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","longName":"disease_type","context":"GDC","contextVersion":"1","DataElementConcept":{"publicId":"6160878","version":"1","preferredName":"International Classification of Diseases for Oncology Malignant Neoplasm","preferredDefinition":"The International Classification of Diseases for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)_A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","longName":"6160876v1.0:2716428v1.0","context":"GDC","contextVersion":"1","ObjectClass":{"publicId":"6160876","version":"1","preferredName":"International Classification of Diseases for Oncology","preferredDefinition":"The International Classification of Diseases for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)","longName":"C37978","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Classification of Diseases for Oncology","conceptCode":"C37978","definition":"The International Classification of Diseases for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F797F1-D86D-4D45-E053-F662850AA0F2","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-04-03","modifiedBy":"ONEDATA","dateModified":"2018-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2716428","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41B66B25-1221-583A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-20","modifiedBy":"ONEDATA","dateModified":"2007-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F797F1-D87B-4D45-E053-F662850AA0F2","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-04-03","modifiedBy":"COOPERM","dateModified":"2020-08-17","changeDescription":"Created for Priority 3 of caDSR Requests Q12018 Dictionary Updates for Review (supplement). 3.14.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6156320","version":"1","preferredName":"ICD-O Disease Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"6156320v1.0","context":"GDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Miscellaneous Bone Tumors","valueDescription":"Miscellaneous Bone Neoplasm","ValueMeaning":{"publicId":"6156321","version":"1","preferredName":"Miscellaneous Bone Neoplasm","longName":"6156321","preferredDefinition":"Diverse, mixed, consisting of an assortment of different kinds.: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Miscellaneous","conceptCode":"C69023","definition":"Diverse, mixed, consisting of an assortment of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bone Neoplasm","conceptCode":"C9343","definition":"A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EE61-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EE7A-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Mesothelial Neoplasms","valueDescription":"Mesothelial Neoplasm","ValueMeaning":{"publicId":"6156323","version":"1","preferredName":"Mesothelial Neoplasm","longName":"6156323","preferredDefinition":"A benign or malignant neoplasm arising from mesothelial cells.  Mesothelial cells are the lining cells of the pleura and peritoneum. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesothelial Neoplasm","conceptCode":"C3786","definition":"A neoplasm characterized by the proliferation of neoplastic mesothelial cells. It usually arises from the pleura or peritoneum. This category includes malignant mesothelioma, adenomatoid tumor (benign mesothelioma), well differentiated papillary mesothelial tumor, and multicystic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EE87-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EEA0-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Mesonephromas","valueDescription":"Mesonephric Neoplasm","ValueMeaning":{"publicId":"6156325","version":"1","preferredName":"Mesonephric Neoplasm","longName":"6156325","preferredDefinition":"An epithelial neoplasm of the female reproductive system arising from mesonephric remnants.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesonephric Neoplasm","conceptCode":"C4295","definition":"An epithelial neoplasm of the female reproductive system arising from mesonephric remnants.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EEAD-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EEC6-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Meningiomas","valueDescription":"Meningioma","ValueMeaning":{"publicId":"4265263","version":"1","preferredName":"Meningioma","longName":"4265263","preferredDefinition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningioma","conceptCode":"C3230","definition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade 1 tumors, and some are WHO grade 2 or 3 tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4D52-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EEDA-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Mature T- and NK-Cell Lymphomas","valueDescription":"Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"2593093","version":"1","preferredName":"Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma","longName":"2593093","preferredDefinition":"A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma","conceptCode":"C3468","definition":"This type of lymphoma is not frequently seen in the western hemisphere. Clinically, with the exception of anaplastic large cell lymphoma, mature T- and NK-cell lymphomas are among the most aggressive of all hematopoietic neoplasms. Representative disease entities include mycosis fungoides, angioimmunoblastic T-cell lymphoma, hepatosplenic T-cell lymphoma, and anaplastic large cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286BA529-8FE0-7325-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EEEE-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Mature B-Cell Lymphomas","valueDescription":"Mature B-Cell Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"3251333","version":"1","preferredName":"Mature B-Cell Non-Hodgkin Lymphoma","longName":"3251333","preferredDefinition":"A non-Hodgkin lymphoma that originates from mature B lymphocytes. Representative examples include diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, and small lymphocytic lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mature B-Cell Non-Hodgkin Lymphoma","conceptCode":"C7056","definition":"A non-Hodgkin lymphoma that originates from mature B lymphocytes. Representative examples include diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, and small lymphocytic lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9CCE-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"COOPERM","dateModified":"2011-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EF02-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Mast Cell Tumors","valueDescription":"Mast Cell Neoplasm","ValueMeaning":{"publicId":"4264929","version":"1","preferredName":"Mast Cell Neoplasm","longName":"4264929","preferredDefinition":"A heterogeneous group of disorders characterized by the abnormal growth and accumulation of mast cells in one or more organ systems.  Recent data suggest that most variants of mast cell neoplasms are clonal disorders. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mast Cell Neoplasm","conceptCode":"C9295","definition":"A heterogeneous group of disorders characterized by the abnormal growth and accumulation of mast cells in one or more organ systems.  Recent data suggest that most variants of mast cell neoplasms are clonal disorders. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67FEF75-A0C5-6988-E040-BB89AD432041","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EF16-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Malignant Lymphomas, NOS or Diffuse","valueDescription":"Not Otherwise Specified or Diffuse Lymphoma","ValueMeaning":{"publicId":"6156326","version":"1","preferredName":"Not Otherwise Specified or Diffuse Lymphoma","longName":"6156326","preferredDefinition":"Not characterized in any other way.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Widely spread; not localized or confined.: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EF26-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EF3F-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Lymphoid Leukemias","valueDescription":"Lymphoid Leukemia","ValueMeaning":{"publicId":"2959432","version":"1","preferredName":"Lymphoid Leukemia","longName":"2959432","preferredDefinition":"A malignant lymphocytic neoplasm of B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood.  This category includes precursor or acute lymphoblastic leukemias and chronic leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoid Leukemia","conceptCode":"C7539","definition":"A malignant lymphocytic neoplasm of B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood.  This category includes precursor or acute lymphoblastic leukemias and chronic leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB37D5-02F2-92F5-E040-BB89AD433DB6","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EF53-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Lymphatic Vessel Tumors","valueDescription":"Lymphatic Vessel Neoplasm","ValueMeaning":{"publicId":"6156328","version":"1","preferredName":"Lymphatic Vessel Neoplasm","longName":"6156328","preferredDefinition":"A benign or malignant neoplasm arising from the lymphatic vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphatic Vessel Neoplasm","conceptCode":"C3723","definition":"A benign or malignant neoplasm arising from the lymphatic vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EF61-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EF7A-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Lipomatous Neoplasms","valueDescription":"Lipomatous Neoplasm","ValueMeaning":{"publicId":"6156330","version":"1","preferredName":"Lipomatous Neoplasm","longName":"6156330","preferredDefinition":"A benign, intermediate, or malignant mesenchymal neoplasm composed of adipose (fatty) tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipomatous Neoplasm","conceptCode":"C4248","definition":"A benign, intermediate, or malignant mesenchymal neoplasm composed of adipose (fatty) tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EF87-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EFA0-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Leukemias, NOS","valueDescription":"Not Otherwise Specified Leukemia","ValueMeaning":{"publicId":"2672865","version":"1","preferredName":"Not Otherwise Specified Leukemia","longName":"2672865","preferredDefinition":"Not characterized in any other way.: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D197D9-8627-49A4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EFB4-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Immunoproliferative Diseases","valueDescription":"Immunoproliferative Disease","ValueMeaning":{"publicId":"6156332","version":"1","preferredName":"Immunoproliferative Disease","longName":"6156332","preferredDefinition":"A clonal disorder, also known as immunoproliferative small intestinal disease or Mediterranean lymphoma, characterised by the secretion of a defective alpha heavy chain.  It predominantly affects young people in the Mediterranean region.  It involves the small intestine, and patients usually present with malabsorption syndrome, abdominal pain, weight loss, and fever.  There is extensive villous atrophy of the small intestinal mucosa, which is heavily infiltrated by small lymphocytes and plasma cells.  The small intestinal morphologic changes are consistent with a mucosa-associated lymphoid tissue lymphoma (MALT lymphoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha Heavy Chain Disease","conceptCode":"C3132","definition":"A clonal disorder, also known as immunoproliferative small intestinal disease or Mediterranean lymphoma, characterized by the secretion of a defective alpha heavy chain. It predominantly affects young people in the Mediterranean region. It involves the small intestine, and patients usually present with malabsorption syndrome, abdominal pain, weight loss, and fever. There is extensive villous atrophy of the small intestinal mucosa, which is heavily infiltrated by small lymphocytes and plasma cells. The small intestinal morphologic changes are consistent with a mucosa-associated lymphoid tissue lymphoma (MALT lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EFC1-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EFDA-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Hodgkin Lymphoma","valueDescription":"Hodgkin Lymphoma","ValueMeaning":{"publicId":"4981811","version":"1","preferredName":"Hodgkin Lymphoma","longName":"4981811","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of large tumor cells in an abundant admixture of nonneoplastic cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E139787-9898-E8CC-E050-BB89AD435F1A","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-EFE4-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Granular Cell Tumors and Alveolar Soft Part Sarcomas","valueDescription":"Granular Cell Tumor and Alveolar Soft Part Sarcoma","ValueMeaning":{"publicId":"6156333","version":"1","preferredName":"Granular Cell Tumor and Alveolar Soft Part Sarcoma","longName":"6156333","preferredDefinition":"An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granular Cell Tumor","conceptCode":"C3474","definition":"An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alveolar Soft Part Sarcoma","conceptCode":"C3750","definition":"A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EFF3-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F00C-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Gliomas","valueDescription":"Glioma","ValueMeaning":{"publicId":"5043642","version":"1","preferredName":"Glioma","longName":"5043642","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2434C622-BEA6-E3B1-E050-BB89AD43792A","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F020-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Giant Cell Tumors","valueDescription":"Giant Cell Tumor","ValueMeaning":{"publicId":"3249738","version":"1","preferredName":"Giant Cell Tumor","longName":"3249738","preferredDefinition":"A benign or malignant connective and soft tissue tumor, characterized by the presence of multinucleated osteoclast-like giant cells.  Representative examples include the giant cell tumor of bone and the giant cell tumor of tendon sheath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Tumor","conceptCode":"C3055","definition":"A benign, intermediate, or malignant tumor that arises from the bone or soft tissue. It is characterized by the presence of multinucleated osteoclast-like giant cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-3940-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F034-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Germ Cell Neoplasms","valueDescription":"Germ Cell Tumor","ValueMeaning":{"publicId":"4265239","version":"1","preferredName":"Germ Cell Tumor","longName":"4265239","preferredDefinition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell Tumor","conceptCode":"C3708","definition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-7893-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"TAYLORT","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F048-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Fibromatous Neoplasms","valueDescription":"Fibromatosis","ValueMeaning":{"publicId":"2566473","version":"1","preferredName":"Fibromatosis","longName":"2566473","preferredDefinition":"A poorly circumscribed neoplasm arising from the soft tissues. It is characterized by the presence of spindle-shaped fibroblasts and an infiltrative growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibromatosis","conceptCode":"C3042","definition":"A poorly circumscribed neoplasm arising from the soft tissues. It is characterized by the presence of spindle-shaped fibroblasts and an infiltrative growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F05C-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Fibroepithelial Neoplasms","valueDescription":"Fibroepithelial Neoplasm","ValueMeaning":{"publicId":"6156335","version":"1","preferredName":"Fibroepithelial Neoplasm","longName":"6156335","preferredDefinition":"A benign, borderline, or malignant neoplasm characterized by the presence of an epithelial and a fibrous component.  Representative examples are fibroadenoma and phyllodes tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibroepithelial Neoplasm","conceptCode":"C3743","definition":"A benign, borderline, or malignant neoplasm characterized by the presence of an epithelial and a fibrous component.  Representative examples are fibroadenoma and phyllodes tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F069-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F082-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Epithelial Neoplasms, NOS","valueDescription":"Not Otherwise Specified Epithelial Neoplasm","ValueMeaning":{"publicId":"6156336","version":"1","preferredName":"Not Otherwise Specified Epithelial Neoplasm","longName":"6156336","preferredDefinition":"Not characterized in any other way.: A benign or malignant neoplasm that arises from and is composed of epithelial cells. This category include adenomas, papillomas, and carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epithelial Neoplasm","conceptCode":"C3709","definition":"A benign or malignant neoplasm that arises from and is composed of epithelial cells. This category include adenomas, papillomas, and carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F08F-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F0A8-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Ductal and Lobular Neoplasms","valueDescription":"Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ","ValueMeaning":{"publicId":"3249010","version":"1","preferredName":"Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ","longName":"3249010","preferredDefinition":"The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ","conceptCode":"C4195","definition":"The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1556-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F0BC-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Cystic, Mucinous and Serous Neoplasms","valueDescription":"Cystic Neoplasm Mucinous Neoplasm and Serous Neoplasm","ValueMeaning":{"publicId":"6156339","version":"1","preferredName":"Cystic Neoplasm Mucinous Neoplasm and Serous Neoplasm","longName":"6156339","preferredDefinition":"A benign or malignant neoplasm that contains a single or multiple cystic spaces.  Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma.: No Value Exists: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cystic Neoplasm","conceptCode":"C6784","definition":"A benign or malignant neoplasm that contains a single or multiple cystic spaces.  Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Mucinous Neoplasm","conceptCode":"C7070","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Serous Neoplasm","conceptCode":"C7074","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F0CD-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F0E6-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Complex Mixed and Stromal Neoplasms","valueDescription":"Complex Mixed and Stromal Neoplasm","ValueMeaning":{"publicId":"6156340","version":"1","preferredName":"Complex Mixed and Stromal Neoplasm","longName":"6156340","preferredDefinition":"Hard, involved or complicated, elaborate, having many parts.: Mixed; being composed of a combination of normal and tumor cells.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A benign or malignant mesenchymal neoplasm composed of stromal cells.  Representative examples include gastrointestinal stromal tumor, endometrial stromal sarcoma, and prostate stromal sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complex","conceptCode":"C47881","definition":"Hard, involved or complicated, elaborate, having many parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Mixed (Normal and Tumor)","conceptCode":"C26457","definition":"Mixed; being composed of a combination of normal and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stromal Neoplasm","conceptCode":"C6781","definition":"A benign or malignant mesenchymal neoplasm composed of stromal cells.  Representative examples include gastrointestinal stromal tumor, endometrial stromal sarcoma, and prostate stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F0F5-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F10E-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Chronic Myeloproliferative Disorders","valueDescription":"Chronic Myeloproliferative Neoplasm","ValueMeaning":{"publicId":"6156341","version":"1","preferredName":"Chronic Myeloproliferative Neoplasm","longName":"6156341","preferredDefinition":"Usually used to describe a condition that is persistent and long standing.: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Myeloproliferative Neoplasm","conceptCode":"C4345","definition":"A group of myeloid neoplasms that includes the following: chronic myeloid leukemia, BCR-ABL1 positive; polycythemia vera; essential thrombocythemia;  primary myelofibrosis; chronic neutrophilic leukemia; chronic eosinophilic leukemia, not otherwise specified; and myeloproliferative neoplasm, unclassifiable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F11B-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F134-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Blood Vessel Tumors","valueDescription":"Blood Vessel Neoplasm","ValueMeaning":{"publicId":"6156343","version":"1","preferredName":"Blood Vessel Neoplasm","longName":"6156343","preferredDefinition":"A neoplasm arising from arteries or veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Vessel Neoplasm","conceptCode":"C7387","definition":"A neoplasm arising from arteries or veins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F141-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F15A-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Basal Cell Neoplasms","valueDescription":"Basal Cell Neoplasm","ValueMeaning":{"publicId":"3626733","version":"1","preferredName":"Basal Cell Neoplasm","longName":"3626733","preferredDefinition":"A neoplastic proliferation of basal cells in the epidermis (part of the skin) or other anatomic sites (most frequently the salivary glands).  The basal cell neoplastic proliferation in the epidermis results in basal cell carcinomas.  The basal cell neoplastic proliferation in the salivary glands can be benign, resulting in basal cell adenomas or malignant, resulting in basal cell adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basal Cell Neoplasm","conceptCode":"C3784","definition":"A neoplastic proliferation of basal cells in the epidermis (part of the skin) or other anatomic sites (most frequently the salivary glands).  The basal cell neoplastic proliferation in the epidermis results in basal cell carcinomas.  The basal cell neoplastic proliferation in the salivary glands can be benign, resulting in basal cell adenomas or malignant, resulting in basal cell adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEA36DD9-7089-2AFD-E040-BB89AD4344B7","latestVersionIndicator":"Yes","beginDate":"2012-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F16E-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Adnexal and Skin Appendage Neoplasms","valueDescription":"Adnexal Carcinoma and Skin Appendage Neoplasm","ValueMeaning":{"publicId":"6156345","version":"1","preferredName":"Adnexal Carcinoma and Skin Appendage Neoplasm","longName":"6156345","preferredDefinition":"A carcinoma arising from the sebaceous glands, sweat glands, or the hair follicles. Representative examples include sebaceous carcinoma, apocrine carcinoma, eccrine carcinoma, and pilomatrical carcinoma.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A benign or malignant neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adnexal Carcinoma","conceptCode":"C3775","definition":"A carcinoma arising from the sebaceous glands, sweat glands, or the hair follicles. Representative examples include sebaceous carcinoma, apocrine carcinoma, eccrine carcinoma, and pilomatrical carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Skin Appendage Neoplasm","conceptCode":"C4463","definition":"A benign or malignant neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F17E-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F197-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Adenomas and Adenocarcinomas","valueDescription":"Adenoma and Adenocarcinoma","ValueMeaning":{"publicId":"6156346","version":"1","preferredName":"Adenoma and Adenocarcinoma","longName":"6156346","preferredDefinition":"A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenoma","conceptCode":"C2855","definition":"A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F1A5-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F1BE-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Acinar Cell Neoplasms","valueDescription":"Acinar Cell Neoplasm","ValueMeaning":{"publicId":"6156348","version":"1","preferredName":"Acinar Cell Neoplasm","longName":"6156348","preferredDefinition":"A benign or malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. It includes the acinar cell adenoma and acinar cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acinar Cell Neoplasm","conceptCode":"C4197","definition":"A benign or malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. It includes the acinar cell adenoma and acinar cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-F1CB-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A3820C-F1E4-5640-E053-F662850AA127","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CE99-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Trophoblastic neoplasms","valueDescription":"Trophoblastic Tumor","ValueMeaning":{"publicId":"3211502","version":"1","preferredName":"Trophoblastic Tumor","longName":"3211502","preferredDefinition":"A gestational or non-gestational neoplasm composed of neoplastic trophoblastic cells. Representative examples include hydatidiform mole and choriocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trophoblastic Tumor","conceptCode":"C3422","definition":"A gestational or non-gestational neoplasm characterized by excessive proliferation of trophoblastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0753-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CEAD-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572578","version":"1","preferredName":"Not Reported","longName":"2572578","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"DWARZEL","dateModified":"2018-03-26","changeDescription":"03/09/2011 - tc - Updated with concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CE8F-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Transitional Cell Papillomas and Carcinomas","valueDescription":"Transitional Cell Papilloma and Transitional Cell Carcinoma","ValueMeaning":{"publicId":"6156448","version":"1","preferredName":"Transitional Cell Papilloma and Transitional Cell Carcinoma","longName":"6156448","preferredDefinition":"A benign papillary neoplasm composed of transitional cells which show preservation of the nuclear polarity.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transitional Cell Papilloma","conceptCode":"C4115","definition":"A benign papillary neoplasm composed of transitional cells which show preservation of the nuclear polarity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transitional Cell Carcinoma","conceptCode":"C2930","definition":"A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CEBD-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CED6-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Thymic Epithelial Neoplasms","valueDescription":"Combined Thymic Epithelial Neoplasm","ValueMeaning":{"publicId":"6156450","version":"1","preferredName":"Combined Thymic Epithelial Neoplasm","longName":"6156450","preferredDefinition":"A primary thymic epithelial neoplasm, characterized by the presence of at least two distinct areas, one representing a thymoma and the other a carcinoma.  The most aggressive component usually determines the clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined Thymic Epithelial Neoplasm","conceptCode":"C45722","definition":"A primary thymic epithelial neoplasm, characterized by the presence of at least two distinct areas, one representing a thymoma and the other a carcinoma.  The most aggressive component usually determines the clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CEE3-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CEFC-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Synovial-like Neoplasms","valueDescription":"Synovial Neoplasm","ValueMeaning":{"publicId":"6156452","version":"1","preferredName":"Synovial Neoplasm","longName":"6156452","preferredDefinition":"A benign or malignant soft tissue neoplasm arising exclusively from the synovial membrane.  Examples include the diffuse giant cell tumor of tendon sheath, localized giant cell tumor of tendon sheath, and malignant giant cell tumor of tendon sheath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Neoplasm","conceptCode":"C8964","definition":"A benign or malignant soft tissue neoplasm arising exclusively from the synovial membrane.  Examples include the diffuse giant cell tumor of tendon sheath, localized giant cell tumor of tendon sheath, and malignant giant cell tumor of tendon sheath.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CF09-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CF22-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Squamous Cell Neoplasms","valueDescription":"Squamous Cell Neoplasm","ValueMeaning":{"publicId":"6156454","version":"1","preferredName":"Squamous Cell Neoplasm","longName":"6156454","preferredDefinition":"A neoplasm that is composed of squamous epithelial cells.  Squamous cell carcinoma is a representative example.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Neoplasm","conceptCode":"C3792","definition":"A neoplasm that is composed of squamous epithelial cells.  Squamous cell carcinoma is a representative example.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CF2F-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CF48-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Specialized Gonadal Neoplasms","valueDescription":"Specialized Gonadal Neoplasm","ValueMeaning":{"publicId":"6156455","version":"1","preferredName":"Specialized Gonadal Neoplasm","longName":"6156455","preferredDefinition":"Specialized Gonadal Neoplasm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CF52-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CF6B-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Soft Tissue Tumors and Sarcomas, NOS","valueDescription":"Soft Tissue Neoplasm and Soft Tissue Sarcoma","ValueMeaning":{"publicId":"6156456","version":"1","preferredName":"Soft Tissue Neoplasm and Soft Tissue Sarcoma","longName":"6156456","preferredDefinition":"A benign, intermediate, or malignant neoplasm that arises from the soft tissue.  The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Neoplasm","conceptCode":"C3377","definition":"A benign, intermediate, or malignant neoplasm that arises from the soft tissue.  The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CF79-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CF92-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Precursor Cell Lymphoblastic Lymphoma","valueDescription":"Lymphoblastic Lymphoma","ValueMeaning":{"publicId":"3210725","version":"1","preferredName":"Lymphoblastic Lymphoma","longName":"3210725","preferredDefinition":"A lymphoma composed of immature small to medium-sized precursor lymphoid cells (lymphoblasts). It includes the B- and T-cell lymphoblastic lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoblastic Lymphoma","conceptCode":"C9360","definition":"A lymphoma composed of immature small to medium-sized precursor lymphoid cells (lymphoblasts). It includes the B- and T-cell lymphoblastic lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-94D8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CFA6-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Plasma Cell Tumors","valueDescription":"Plasma Cell Neoplasm","ValueMeaning":{"publicId":"2593071","version":"1","preferredName":"Plasma Cell Neoplasm","longName":"2593071","preferredDefinition":"An unusual leukemia characterized by the presence of clonal (malignant) plasma cells in the peripheral blood.  The plasma cells infiltrate the spleen, liver, bone marrow, and lymph nodes. The total number of leukocytes in the peripheral blood may range from normal levels to 80,000 or 90,000 per cu mm, and 5% to 90% may be plasma cells.  Although there are clinicopathologic differences between plasma cell leukemia and plasma cell myeloma, they may be phases of the same malignant process. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plasma Cell Neoplasm","conceptCode":"C4665","definition":"A clonal proliferation of immunoglobulin-secreting plasma cells. This category includes multiple myeloma, plasma cell leukemia, plasmacytoma, and plasma cell post-transplant lymphoproliferative disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286C5855-1934-6248-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CFBA-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Paragangliomas and Glomus Tumors","valueDescription":"Paraganglioma And Glomus Tumor","ValueMeaning":{"publicId":"6156457","version":"1","preferredName":"Paraganglioma And Glomus Tumor","longName":"6156457","preferredDefinition":"A benign or malignant neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A rare benign or malignant mesenchymal neoplasm arising from cells that resemble the modified smooth muscle cells of the glomus body. The majority of glomus tumors occur in the distal extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paraganglioma","conceptCode":"C3308","definition":"A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glomus Tumor","conceptCode":"C3060","definition":"A rare benign or malignant mesenchymal neoplasm arising from cells that resemble the modified smooth muscle cells of the glomus body. The majority of glomus tumors occur in the distal extremities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-CFC8-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CFE1-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Other Leukemias","valueDescription":"Other Leukemia","ValueMeaning":{"publicId":"3928352","version":"1","preferredName":"Other Leukemia","longName":"3928352","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-4706-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-CFF5-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Other Hematologic Disorders","valueDescription":"Other Hematologic and Lymphocytic Disorder","ValueMeaning":{"publicId":"6156458","version":"1","preferredName":"Other Hematologic and Lymphocytic Disorder","longName":"6156458","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematopoietic and Lymphoid Cell Disorder","conceptCode":"C26323","definition":"A non-neoplastic or neoplastic disorder that arises from the hematopoietic and lymphoid cells. Representative examples include disorders that affect the synthesis of hemoglobin, coagulation disorders, leukemias, and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D002-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D01B-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Osseous and Chondromatous Neoplasms","valueDescription":"Osteogenic Neoplasm and Chondrogenic Neoplasm","ValueMeaning":{"publicId":"6156461","version":"1","preferredName":"Osteogenic Neoplasm and Chondrogenic Neoplasm","longName":"6156461","preferredDefinition":"A benign, intermediate, or malignant bone-forming neoplasm. Representative examples include osteoma, osteoblastoma, and osteosarcoma.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A benign, intermediate, or malignant cartilaginous matrix-producing neoplasm.  Representative examples include osteochondroma, chondroblastoma, and chondrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteogenic Neoplasm","conceptCode":"C6603","definition":"A benign, intermediate, or malignant bone-forming neoplasm. Representative examples include osteoma, osteoblastoma, and osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chondrogenic Neoplasm","conceptCode":"C4755","definition":"A benign, intermediate, or malignant cartilaginous matrix-producing neoplasm.  Representative examples include osteochondroma, chondroblastoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D02B-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D044-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Odontogenic Tumors","valueDescription":"Odontogenic Neoplasm","ValueMeaning":{"publicId":"6156463","version":"1","preferredName":"Odontogenic Neoplasm","longName":"6156463","preferredDefinition":"A benign or malignant neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Benign tumors are slow growing and are not associated with specific clinical symptoms. Pain is absent or slight. Malignant tumors are usually associated with rapid swelling and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Odontogenic Neoplasm","conceptCode":"C3286","definition":"A benign or malignant neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Benign neoplasms are slow growing and are not associated with specific clinical symptoms. Pain is absent or slight. Malignant neoplasms are usually associated with rapid swelling and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D051-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D06A-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Nevi and Melanomas","valueDescription":"Melanocytic Nevus and Melanoma","ValueMeaning":{"publicId":"6156464","version":"1","preferredName":"Melanocytic Nevus and Melanoma","longName":"6156464","preferredDefinition":"A neoplasm composed of melanocytes that usually appears as a dark spot on the skin.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanocytic Nevus","conceptCode":"C7570","definition":"A neoplasm composed of melanocytes that usually appears as a dark spot on the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D078-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COOPERM","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D091-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Neuroepitheliomatous Neoplasms","valueDescription":"Neuroepithelial Neoplasm","ValueMeaning":{"publicId":"6156466","version":"1","preferredName":"Neuroepithelial Neoplasm","longName":"6156466","preferredDefinition":"A neoplasm of the nervous system that arises from the neuroepithelial tissues.  Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroepithelial Neoplasm","conceptCode":"C3787","definition":"A neoplasm of the nervous system that arises from the neuroepithelial tissues.  Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D09E-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D0B7-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Nerve Sheath Tumors","valueDescription":"Nerve Sheath Neoplasm","ValueMeaning":{"publicId":"6156467","version":"1","preferredName":"Nerve Sheath Neoplasm","longName":"6156467","preferredDefinition":"A benign or malignant neoplasm arising from the perineural cells in the sheaths surrounding the nerves. Representative examples include neurofibroma, schwannoma, and malignant peripheral nerve sheath tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nerve Sheath Neoplasm","conceptCode":"C4972","definition":"A benign or malignant neoplasm arising from the perineural cells in the sheaths surrounding the nerves. Representative examples include neurofibroma, schwannoma, and malignant peripheral nerve sheath tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D0C3-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D0DC-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Neoplasms of Histiocytes and Accessory Lymphoid Cells","valueDescription":"Neoplasms of Histiocytes and Accessory Lymphoid Cells","ValueMeaning":{"publicId":"6156468","version":"1","preferredName":"Neoplasms of Histiocytes and Accessory Lymphoid Cells","longName":"6156468","preferredDefinition":"Neoplasms of Histiocytes and Accessory Lymphoid Cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D0E6-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D0FF-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Neoplasms, NOS","valueDescription":"Not Otherwise Specified Neoplasm","ValueMeaning":{"publicId":"6156469","version":"1","preferredName":"Not Otherwise Specified Neoplasm","longName":"6156469","preferredDefinition":"Not characterized in any other way.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D10C-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D125-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Myxomatous Neoplasms","valueDescription":"Myxoma","ValueMeaning":{"publicId":"4265261","version":"1","preferredName":"Myxoma","longName":"4265261","preferredDefinition":"A benign soft tissue neoplasm characterized by the presence of spindle and stellate cells, lobulated growth pattern, and myxoid stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoma","conceptCode":"C6577","definition":"A benign soft tissue neoplasm characterized by the presence of spindle and stellate cells, lobulated growth pattern, and myxoid stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4CF4-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D139-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Myomatous Neoplasms","valueDescription":"Myomatous Neoplasm","ValueMeaning":{"publicId":"6156471","version":"1","preferredName":"Myomatous Neoplasm","longName":"6156471","preferredDefinition":"A benign or malignant mesenchymal neoplasm arising from smooth, skeletal, or cardiac muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myomatous Neoplasm","conceptCode":"C4063","definition":"A benign or malignant mesenchymal neoplasm arising from smooth, skeletal, or cardiac muscle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D147-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D160-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Myeloid Leukemias","valueDescription":"Myeloid Leukemia","ValueMeaning":{"publicId":"4903679","version":"1","preferredName":"Myeloid Leukemia","longName":"4903679","preferredDefinition":"A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are immature myeloid cells and myeloblasts, it is called acute myeloid leukemia. When the proliferating myeloid cells are neutrophils, it is called chronic myelogenous leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloid Leukemia","conceptCode":"C3172","definition":"A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are immature myeloid cells and myeloblasts, it is called acute myeloid leukemia. When the proliferating myeloid cells are neutrophils, it is called chronic myelogenous leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B153AB5-0D14-4322-E050-BB89AD433CC8","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D174-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Myelodysplastic Syndromes","valueDescription":"Myelodysplastic Syndrome","ValueMeaning":{"publicId":"3946618","version":"1","preferredName":"Myelodysplastic Syndrome","longName":"3946618","preferredDefinition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome","conceptCode":"C3247","definition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA87B0E5-6712-6876-E040-BB89AD437204","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-06","modifiedBy":"GDEEN","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D188-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Mucoepidermoid Neoplasms","valueDescription":"Mucoepidermoid Carcinoma","ValueMeaning":{"publicId":"3704622","version":"1","preferredName":"Mucoepidermoid Carcinoma","longName":"3704622","preferredDefinition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3B3E-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D19C-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Miscellaneous Tumors","valueDescription":"Miscellaneous Neoplasm","ValueMeaning":{"publicId":"4722607","version":"1","preferredName":"Miscellaneous Neoplasm","longName":"4722607","preferredDefinition":"A benign or malignant neoplasm which is not further characterized.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Miscellaneous Neoplasm","conceptCode":"C102883","definition":"A benign or malignant neoplasm which is not further characterized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F9CA-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68A4C0CD-D1B0-142E-E053-F662850AC3EC","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADCCDC77-4EF6-795F-E053-4EBD850A458D","beginDate":"2020-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-08-26","modifiedBy":"ONEDATA","dateModified":"2020-08-26","deletedIndicator":"No"},{"value":"Complex Epithelial Neoplasm","valueDescription":"Complex Epithelial Neoplasm","ValueMeaning":{"publicId":"7409232","version":"1","preferredName":"Complex Epithelial Neoplasm","longName":"7409232","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complex Epithelial Neoplasm","conceptCode":"C4198","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADCCDC77-4F04-795F-E053-4EBD850A458D","latestVersionIndicator":"Yes","beginDate":"2020-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-08-26","modifiedBy":"ONEDATA","dateModified":"2020-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADCCDC77-4F1D-795F-E053-4EBD850A458D","beginDate":"2020-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-08-26","modifiedBy":"ONEDATA","dateModified":"2020-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EE46-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"COLBERTM","dateModified":"2020-08-26","changeDescription":"Created for Priority 3 of caDSR Requests Q12018 Dictionary Updates for Review (supplement). 3.14.18 mc   Confirmed list and released VD after verification of the property in the GDC data dictionary. 8/26/20 MRC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428032","version":"1","longName":"Case","context":"GDC","ClassificationSchemeItems":[{"publicId":"5428033","version":"1","longName":"Case","context":"GDC"}]}],"AlternateNames":[{"name":"CRDC","type":"USED_BY","context":"CRDC"}],"ReferenceDocuments":[{"name":"Disease type","type":"Preferred Question Text","description":"Disease type","url":null,"context":"GDC"},{"name":"CDS","type":"EXAMPLE","description":"Acinar Cell Neoplasm, Basal Cell Neoplasm, Blood Vessel Neoplasm","url":null,"context":"CRDC"}],"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6905C2C7-BD64-63DC-E053-F662850AB992","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-04-04","modifiedBy":"COLBERTM","dateModified":"2023-05-01","changeDescription":"3/1/22 jk Designated, added CDS alt name and CSI. ---  Created for Priority 3 of caDSR Requests Q12018 Dictionary Updates for Review (supplement). 3.14.18 mc   Released DE after verification of the property in the GDC data dictionary. 8/26/20 MRC","administrativeNotes":"5/1/23 Removed CDS CSI and alt name/def. mr\r\n1/25/23 removed CDS CDE CSI and alt names; CDS using DSS CDE. jk;  1/23/23 Added CDS ref doc EXAMPLE; removed general CDS CSI, added CDS|dIAGNOSISCSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}